Prevalence of sleep disturbances in patients with long COVID assessed by standardised questionnaires and diagnostic criteria: A systematic review and meta-analysis

Chinvararak, Chotiman; Chalder, Trudie

doi:10.1016/j.jpsychores.2023.111535

Cited by 9 publications

(4 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings using the PROMIS-SD framework have not significantly deviated from the range found in the meta-analysis noted above. 6 Our results provide preliminary support that the PROMIS framework, specifically the sleep disturbance domain, can be used to assess the presence of sleep disturbance. Furthermore, PROMIS-SD is correlated to other sleep questionnaires, such as the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index.…”

Section: Discussionsupporting

confidence: 57%

“…In comparison, a recent meta-analysis estimates a pooled prevalence of sleep disturbances at 46% (95th percentile confidence interval of 38%-54%). 6 Differences in study sample sizes, the definition of sequelae, reported symptoms and duration of symptoms contribute to the wide range in reported prevalence. Our findings using the PROMIS-SD framework have not significantly deviated from the range found in the meta-analysis noted above.…”

Section: Discussionmentioning

confidence: 99%

“…The analysis centered on studies that assessed burden by using standardized sleep disturbance questionnaires, including the Pittsburgh Sleep Quality Index (PSQI), A single-item sleep quality scale (SQS), insomnia severity index (ISI), the Athens insomnia scale (AIS), and the Epworth sleepiness scale (ESS). 6 However, there is limited data in assessing the burden of sleep disturbances using the PROMIS-SD framework.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

A Survey of Sleep Quality From a Post-COVID Clinic

Punj,

Schwartz,

Morris

et al. 2024

J Prim Care Community Health

View full text Add to dashboard Cite

Objectives: To assess the prevalence of sleep disturbance among patients evaluated at a clinic for patients afflicted with Post-acute sequelae of COVID-19 (PASC). Methods: Sleep disturbance was assessed with the Patient-Reported Outcomes Measurement Information System-Sleep Disturbance (PROMIS-SD) framework among adult patients of the PASC clinic. Results: Among 312 patients, the mean age was 46.2 years, and 70.2% were women. About 41.0% of patients had no sleep disturbance; sleep disturbance was mild to moderate in 51.3% and severe in 7.7%. PROMIS-SD score was negatively correlated with the time from the initial positive COVID-19 test to the initial consultation in the PASC clinic (Pearson r = −.094; r2 = .0088). Conclusions: The PROMIS-Sleep Disturbance framework can serve as a tool to assess the burden of sleep disturbances in PASC patients.

show abstract

Section: Discussionsupporting

confidence: 57%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Survey of Sleep Quality From a Post-COVID Clinic

Punj,

Schwartz,

Morris

et al. 2024

J Prim Care Community Health

View full text Add to dashboard Cite

show abstract

“…Systematic literature reviews and meta-analyses on the prevalence of sleep disorders among patients with long COVID have reported an overall prevalence of 46% (95% CI, 38 - 54%). Subgroup analysis indicated that poor sleep quality affected 56% of patients (95% CI, 47 - 65%), insomnia affected 38% (95% CI, 28 - 48%), and excessive daytime sleepiness was present in 14% (95% CI, 0 - 29%) of cases [ 85 ].…”

Section: Diagnosismentioning

confidence: 99%

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

Seo,

Kim,

Kim

et al. 2024

Infect Chemother

View full text Add to dashboard Cite

"Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID.

show abstract

Neurological, psychological, psychosocial complications of long-COVID and their management

Narayanan,

Padiyath,

Chandrababu

et al. 2024

Neurol Sci

View full text Add to dashboard Cite

Since it first appeared, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has had a significant and lasting negative impact on the health and economies of millions of individuals all over the globe. At the level of individual health too, many patients are not recovering fully and experiencing a long-term condition now commonly termed ‘long-COVID’. Long-COVID is a collection of symptoms which must last more than 12 weeks following initial COVID infection, and which cannot be adequately explained by alternate diagnoses. The neurological and psychosocial impact of long-COVID is itself now a global health crisis and therefore preventing, diagnosing, and managing these patients is of paramount importance. This review focuses primarily on: neurological functioning deficits; mental health impacts; long-term mood problems; and associated psychosocial issues, among patients suffering from long-COVID with an eye towards the neurological basis of these symptoms. A concise account of the clinical relevance of the neurological and psychosocial impacts of long-COVID, the effects on long-term morbidity, and varied approaches in managing patients with significant chronic neurological symptoms and conditions was extracted from the literature, analysed and reported. A comprehensive account of plausible pathophysiological mechanisms involved in the development of long-COVID, its management, and future research needs have been discussed.

show abstract

Prevalence of sleep disturbances in patients with long COVID assessed by standardised questionnaires and diagnostic criteria: A systematic review and meta-analysis

Cited by 9 publications

References 44 publications

A Survey of Sleep Quality From a Post-COVID Clinic

A Survey of Sleep Quality From a Post-COVID Clinic

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

Neurological, psychological, psychosocial complications of long-COVID and their management

Contact Info

Product

Resources

About